CompletedNot Applicable

Using Ambu Aura-i Laryngeal Mask Airway in Cranial Surgery

Egypt120 participantsStarted 2020-12-01

Plain-language summary

the investigators hypothesize that Ambu aura-i LMA can be used safely in patients undergoing craniotomies and are effective in reducing the incidence of emergence hypertension.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Study will be conducted on patients undergoing craniotomies under general anaesthesia in supine position.
✓. Aged 18 to 60 years.
✓. ASA 1 or 2.
✓. GCS ≥ 13.

Exclusion criteria

✕. Patients who are known hypertensive, history of cardiac diseases or chest diseases
✕. Patients with risk of aspiration (Obesity with BMI ≥ 40, hiatal hernia, esophageal cancer and previous esophageal surgery).
✕. Risk of difficult intubation
✕. Extensive intracranial tumours that may affect recovery of patients.

What they're measuring

Measure Mean blood pressure

Timeframe: UP TO 1 HOURE

Trial details

NCT IDNCT04582227

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-10

View on ClinicalTrials.gov More Hypertension, Malignant trials